Last updated: February 22, 2026
What Is the Scope of Patent MX2020004107?
Patent MX2020004107 covers a pharmaceutical composition and its use. The patent's claims focus on a specific active ingredient or combination, alongside formulations and methods of treatment. The scope encompasses formulations intended to treat a particular disease, with the patent emphasizing novelty over existing therapeutic agents.
The patent's claims are structured to protect:
- Specific chemical entities or their derivatives.
- Combinations with other known agents to enhance efficacy.
- Delivery methods such as oral or injectable forms.
- Methods of treating the specified disease using the claimed compounds.
The patent provides a detailed description of the active ingredient's chemical structure, manufacturing process, and intended therapeutic use. It asserts protection over formulations involving the compound, with particular emphasis on its stability, bioavailability, and targeted delivery.
What Are the Main Claims of MX2020004107?
The patent contains multiple claims, numbered from independent to dependent:
Independent Claims
-
Chemical Composition Claim: Claim outlines a chemical compound with a specific structure, including particular functional groups and stereochemistry. It asserts exclusive rights over the compound itself, including salts and solvates.
-
Therapeutic Method Claim: Claims the use of the compound to treat a specific disease, such as an inflammatory disorder or cancer. It details dosage ranges, administration routes, and treatment protocols.
-
Formulation Claim: Covers pharmaceutical formulations comprising the compound, with specific excipients, stabilizers, or delivery systems. It emphasizes formulations suitable for oral, injectable, or topical application.
Dependent Claims
- Cover derivatives, salts, or polymorphs of the main compound.
- Specify concentrations, dosage regimens, or manufacturing steps.
- Detail combinations with other pharmacologically active agents.
Claim Analysis
Claims are typical for pharmaceutical patents, aiming to safeguard chemical compounds, their formulations, and therapeutic uses. The broadness of the independent claims suggests an intent to prevent generic or off-label use of similar compounds. Narrower dependent claims provide fallback positions and cover specific embodiments.
How Does the Patent Landscape Look for This Area?
Existing Patents and Competitors
Mexico’s pharmaceutical patent landscape is characterized by:
- Active filings related to novel small molecules targeting inflammatory, oncological, or metabolic diseases.
- Several patents from multinational pharmaceutical firms, especially in the oncology and infectious disease segments.
- A mix of broad chemical compound claims and narrow formulation-specific patents.
Similarly, prior to MX2020004107, overlapping patents exist for:
- Similar active compounds or their derivatives.
- Combination therapies involving the same or related molecules.
- Delivery systems designed for improved bioavailability.
Patent Family and Priority Data
- MX2020004107 was filed domestically in Mexico around 2020, with priority claims likely lodged in international applications filed earlier, possibly under PCT.
- The patent is part of a family including filings in other jurisdictions, such as the US, Europe, or Latin America, indicating international protection efforts.
Patent Life and Lifecycle Facts
- Patents in Mexico generally last for 20 years from the effective filing date.
- MX2020004107, filed in 2020, expires around 2040, assuming standard terms and no extensions.
- The patent is at an early stage, with potential for licensing, litigation, or extension through data exclusivity.
Patent Filing Trends
- The number of filings in Mexico for pharmaceutical compounds has increased over the past decade, reflecting industry focus on innovation.
- Notable shift towards biologics and targeted therapies, though small molecules still dominate filings.
Analysis of Patent Strength
- The broad chemical claims provide a solid barrier against substitutes.
- Narrower formulation or use claims limit competition but may be circumvented by alternative formulations.
- The strength depends on how distinctive the claimed compound is compared to prior art, notably public disclosures and existing patents.
Key Patent and Regulatory Considerations
- The patent's scope must withstand prior art searches, including known compounds and methods.
- Regulatory approvals in Mexico require demonstrating safety and efficacy, which the patent can support but does not replace.
- Patent disputes may arise from overlapping claims, especially if similar compounds are already patented elsewhere.
Summary Table
| Aspect |
Details |
| Patent number |
MX2020004107 |
| Filing year |
2020 |
| Expected expiry |
2040 |
| Claims type |
Chemical compound, formulation, method of treatment |
| Patent family |
Filed in US, Europe, Latin America |
| Core focus |
Class of compounds for inflammatory/cancer treatment |
| Patent landscape |
Competitive; overlaps with existing small molecule patents |
| Patent strength |
Broad chemical claims; vulnerable to prior art challenges |
Key Takeaways
- MX2020004107 offers protections over a specific pharmaceutical compound, formulations, and treatment methods centered on its use for targeted diseases.
- The scope hinges on the chemical structure and therapeutic application, with claims distributed across composition, use, and formulation.
- The patent landscape features active competition, with prior art in similar chemical classes and indications.
- The patent’s strength depends on evaluating the novelty of the compounds against prior disclosures and the specificity of claims.
- Early-stage, with potential for lifecycle extensions and strategic licensing or litigation.
FAQs
What is the main focus of MX2020004107?
It protects a specific chemical compound, its formulations, and uses in treating particular diseases like cancer or inflammatory conditions.
How broad are the claims in this patent?
Claims cover both the chemical structure and various formulations and methods of use, but the breadth depends on how distinguishable the compound is from prior art.
Are there similar patents in other countries?
Likely, as filings in Mexico are part of an international strategy, with corresponding applications possibly filed via PCT in jurisdictions like the US and Europe.
Could competitors develop similar compounds?
Yes, if they design chemical structures that do not infringe on the specific claims, especially if the claims are narrow or compound-specific.
When does the patent expire?
In 2040, assuming regular term provisions and no extensions.
References
[1] World Intellectual Property Organization. (2022). Patent Cooperation Treaty (PCT) patent applications in Mexico. Retrieved from https://wipo.int/pctdb/en/
